TP53 and chronic kidney disease: These results indicate that p53 has an inhibitory effect on osteogenic differentiation of VSMCs in CKD mice, as evidenced by an increase in markers of osteogenic differentiation and a decrease in expression of the smooth muscle-specific marker.